Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 12,531 | 7,321 | 10,629 | 9,055 | 4,612 |
| Gross Profit | 12,531 | 7,321 | 10,629 | 9,055 | 4,612 |
| Operating Expenses | 23,479 | 31,874 | 32,300 | 31,266 | 32,748 |
| Operating Income | -10,948 | -24,553 | -21,671 | -22,211 | -28,136 |
| Other Income | 189 | 220 | 384 | 262 | 349 |
| Pre-tax Income | -10,759 | -24,333 | -21,287 | -21,949 | -27,787 |
| Net Income Continuous | -10,759 | -24,333 | -21,287 | -21,949 | -27,787 |
| Net Income | $-10,759 | $-24,333 | $-21,287 | $-21,949 | $-27,787 |
| EPS Basic Total Ops | -4.80 | -11.80 | -10.40 | -10.80 | -13.60 |
| EPS Basic Continuous Ops | -4.77 | -11.86 | -10.40 | -10.76 | -13.67 |
| EPS Diluted Total Ops | -4.80 | -11.80 | -10.40 | -10.80 | -13.60 |
| EPS Diluted Continuous Ops | -4.77 | -11.86 | -10.40 | -10.76 | -13.67 |
| EBITDA(a) | $-9,027 | $-22,547 | $-19,693 | $-20,304 | $-26,264 |